Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.

Abstract

Tumour suppressor genes (TSGs) were frequently inactivated through promoter hypermethylation in gastric carcinoma as well as pre-malignant gastric lesions, suggesting that promoter hypermethylation can be used as a marker to define novel TSGs and also biomarkers for early detection of gastric cancer. In an effort to search for such genes aberrantly methylated in gastric cancer development, fibulin 1 (FBLN1) was found as a candidate TSG epigenetically downregulated in gastric cancer. FBLN1 expression was downregulated in all of gastric cancer cell lines used (100%, 7 out of 7) and the primary gastric carcinoma tissues (84%, 86 out of 102) and significantly restored after pharmacological demethylation. Hypermethylation of the FBLN1 promoter was frequently (71%, 5 out of 7) detected in gastric cancer cell lines and primary gastric carcinoma tissues. Ectopic expression of FBLN1 led to the growth inhibition of gastric cancer cells through the induction of apoptosis. In summary, FBLN1 was identified as a novel candidate TSG epigenetically downregulated in gastric cancer.

• Authors: Y Y Cheng, H Jin, X Liu, J M T Siu, Y P Wong, E K O Ng, J Yu, W-K Leung, J J Y Sung, F K L Chan
• Journal: British journal of cancer (Br J Cancer) Vol. 99 Issue 12 Pg. 2083-7 (Dec 16 2008) ISSN: 1532-1827 [Electronic] England
• PMID: 18985039 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Aza Compounds
• Calcium-Binding Proteins
• fibulin

Topics

• Aged
• Aza Compounds (pharmacology)
• Calcium-Binding Proteins (genetics, metabolism)
• Cell Line, Tumor
• Cell Proliferation
• DNA Methylation (genetics)
• Down-Regulation (genetics)
• Female
• Gene Expression Regulation, Neoplastic (genetics)
• Humans
• Male
• Promoter Regions, Genetic (genetics)
• Stomach Neoplasms (genetics, metabolism, pathology)
• Up-Regulation (drug effects)